 OXNARD, Calif.--BUSINESS WIRE--CURE Pharmaceutical Holding Corp. OTC: CURR, a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company, BRC, an active Drug Enforcement Administration DEA license holder, to produce federally-compliant cannabis-based medical products. Currently, CURE uses its Schedule 1 DEA license for the development of Cannabis THC oral film products and othe 